New pill for advanced tumors enters first human tests
Disease control
Recruiting now
This early-stage study tests a new daily pill, DEG6498, in about 100 adults with advanced solid tumors that have not responded to other treatments. The main goals are to find a safe dose and check for side effects. Researchers will also measure how the drug moves through the body…
Phase: PHASE1 • Sponsor: Degron Therapeutics Co. • Aim: Disease control
Last updated May 05, 2026 11:55 UTC